Important: This article is for educational purposes only and is not medical advice. Migraine is a treatable neurological condition that should be managed by a primary-care provider, neurologist, or headache specialist. CBD is not approved by the FDA to treat migraines. Sudden severe headache, “thunderclap” headache, headache with neurologic deficit, fever, or stiff neck warrants urgent evaluation.
Migraine is among the most common and disabling neurological conditions, affecting roughly 12% of the population. The treatment landscape has changed substantially in the last several years with the introduction of CGRP-targeted therapies. CBD has appeared in migraine conversations, and the honest answer is that the evidence is preliminary while standard care has improved markedly.
The short version
- CBD is not a treatment for migraines. No CBD product is FDA-approved for migraine prevention or acute treatment.
- Standard migraine care is now multi-modal: trigger identification, lifestyle factors, acute medications (triptans, gepants, ditans, NSAIDs) and preventive medications (beta-blockers, topiramate, valproate, CGRP inhibitors, amitriptyline, others).
- Some preclinical research has examined cannabinoid signaling in pain pathways, but this does not translate into evidence that consumer CBD products treat migraines.
When to seek urgent care
Some headache features warrant urgent evaluation rather than self-management:
- Sudden, severe, “thunderclap” headache (peak intensity in seconds to minutes)
- New headache with fever and stiff neck
- Headache with neurologic deficit (weakness, vision change, speech change)
- New headache after age 50
- Headache with cancer history, immunosuppression, or after head injury
- Progressively worsening headache pattern
These can indicate subarachnoid hemorrhage, meningitis, stroke, mass lesions, or other serious causes.
What migraine actually is
Migraine is more than a headache. It is a neurological disorder involving brain hyperexcitability and trigeminovascular activation. Episodes typically include moderate to severe head pain (often unilateral, often pulsating), sensitivity to light and sound, nausea, and worsening with activity. Some patients experience aura (visual, sensory, or other neurologic symptoms preceding headache).
Subtypes include episodic migraine and chronic migraine (≥15 headache days per month, ≥8 with migraine features).
What CBD-and-migraine research has actually examined
Direct clinical research on consumer CBD products in migraine patients is sparse. Some surveys describe individuals who use cannabis or CBD and report migraine relief, with the usual limitations of self-report data.
A few small studies have examined cannabinoids more broadly in chronic-headache contexts. Findings have been mixed. There is no large randomized trial of CBD specifically for migraine prevention or acute treatment.
What evidence-based migraine care actually looks like
This area has changed substantially in the last decade.
Acute treatment (taken at the start of an attack)
- Triptans (sumatriptan, rizatriptan, others) — first-line for moderate to severe attacks
- Gepants (rimegepant, ubrogepant, zavegepant) — newer CGRP receptor antagonists for acute use
- Ditans (lasmiditan) — for patients who cannot use triptans
- NSAIDs for milder attacks
- Antiemetics for nausea
Preventive treatment (taken daily to reduce frequency)
- Beta-blockers (propranolol, metoprolol)
- Topiramate
- Valproate
- Amitriptyline, venlafaxine
- CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) — game-changer for many patients
- Atogepant, rimegepant — oral CGRP receptor antagonists for prevention
- Onabotulinumtoxin A for chronic migraine
Non-pharmacological
- Trigger identification and avoidance (sleep, hydration, alcohol, specific foods for some patients, stress)
- Cognitive-behavioral therapy and biofeedback have meaningful evidence
- Regular aerobic exercise
Drug-interaction considerations
CBD is metabolized through liver enzymes (CYP3A4 and CYP2C19) shared with several migraine medications, including some preventives (topiramate, valproate, amitriptyline). Discuss any supplement use with the prescribing clinician.
What the FDA has said
The FDA has not approved any CBD product for migraine. The agency has issued warning letters to companies marketing CBD with pain or migraine treatment claims.
Talking to your physician or headache specialist
If you have migraines and are curious about CBD as part of a broader wellness routine, useful questions:
- Have I tried evidence-based acute and preventive options?
- Am I overusing acute medications (medication-overuse headache is a real and reversible cause of chronic daily headache)?
- Are CGRP-targeted therapies appropriate for me?
- Are any of my current medications metabolized through pathways CBD also affects?
What we offer at New Phase Blends
We make third-party-tested CBD products designed for general wellness use. They are not formulated, tested, or marketed as treatments for migraine. If you have migraines, please continue to follow the plan your treating clinician has built for you.
Frequently asked questions
Does CBD treat migraines? No. CBD is not approved for migraine, and the available research does not support marketing CBD products as migraine treatments.
What about CGRP medications? CGRP-targeted therapies (monoclonal antibodies and gepants) have transformed migraine prevention and acute treatment for many patients. If you have not discussed them with your provider, it is worth doing so.
Could my daily headaches be from medication overuse? Possibly. Frequent use of acute migraine medications (triptans, opioids, butalbital-containing products) can produce medication-overuse headache. Reducing the frequency of acute medications under clinical guidance often improves the underlying pattern.
What are good migraine triggers to track? Sleep changes, dehydration, alcohol (especially red wine), missed meals, stress, and weather changes are common. A headache diary can help identify your specific patterns.
Disclaimer: The statements made on this page have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease, including migraine. The information here is for educational purposes only and is not a substitute for advice from a licensed medical professional.
